- Raised $8.3M funding round led by Awz Ventures, Dec 2024
- Raised $700k grant, Jan 2024
About
Promise Bio, a recent spin-out from the Weizmann Institute, is the first company to harness post-translational modifications (PTM) and artificial intelligence to reveal unique biological insights that are otherwise overlooked. Understanding immune-mediated diseases requires uncovering intricate proteomic patterns, and PTMs are the key to capturing the regulated part of the proteome.
The PROMISE platform uses proprietary Comprehensive PTM Profiling to detect up to 45 PTM types simultaneously, allowing maximal knowledge extraction from biological data and offering a unique approach to identifying functional biomarkers from diverse biological samples (PBMCs, tissue biopsies, urine). With a proprietary technology recently published in Nature Biotechnology, we partner with pharmaceutical companies to unleash the potential of their data-driven discovery, by looking at biology where it matters the most for complex chronic diseases.
Funding history · 2 rounds · $9.0M total
Q&A
- What is Promise Bio's primary focus?
- Promise Bio specializes in epiproteomic analyses on standard mass-spectrometry data, utilizing post-translational modifications (PTM) and artificial intelligence to uncover biological insights for immune-mediated diseases.
- When was Promise Bio founded?
- Promise Bio was founded in January 2023.
- How many employees does Promise Bio have?
- Promise Bio has an employee count in the 11-50 range.
- What was Promise Bio's most recent funding round?
- In December 2024, Promise Bio raised $8,300,000 in a funding round led by.
- Has Promise Bio received any grant funding?
- Yes, in January 2024, Promise Bio received a $700,000 grant from the Israel Innovation Authority.
- What is Promise Bio's total amount raised to date?
- Promise Bio has raised a total of $9,000,000 USD.
- What is the current stage of Promise Bio's funding?
- Promise Bio is currently in the Seed funding stage.
- Who is the Co-founder and CEO of Promise Bio?
- Ronel Veksler is the Co-founder and CEO of Promise Bio.
Team · 1
Sectors & technology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | promise.bio/ |
|---|---|
| linkedin.com/company/82083896 |
Identifiers & details
| Founded | 2023-1 |
|---|---|
| Employees (exact) | 14 |
Radar intelligence
Open jobs — ashby
| Total open | 21 |
|---|---|
| Remote | 20 |
| Title | Location | Department |
|---|---|---|
| IT Specialist | ||
| Account Executive - Public Sector | ||
| Bilingual Customer Support Associate (Call Center) | ||
| Product Designer | ||
| Software Engineer - AI | ||
| Data Engineer | ||
| Software Engineer - Platform & Infrastructure | ||
| Forward Deployed Engineer | ||
| Deployment Strategist | ||
| Forward Deployed Engineer | ||
| Software Engineering Lead | ||
| Software Engineer - AI |
Web history (Wayback)
| Domain | promise.bio |
|---|
Certificate / subdomain footprint
| Subdomains | 6 |
|---|